Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Non-cash Items (2016 - 2025)

Altimmune (ALT) has disclosed Non-cash Items for 10 consecutive years, with $4.8 million as the latest value for Q4 2025.

  • Quarterly Non-cash Items fell 17.3% to $4.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.8 million through Dec 2025, down 17.3% year-over-year, with the annual reading at $4.8 million for FY2025, 30.92% up from the prior year.
  • Non-cash Items for Q4 2025 was $4.8 million at Altimmune, up from $1.1 million in the prior quarter.
  • The five-year high for Non-cash Items was $25.7 million in Q4 2022, with the low at $4045.0 in Q1 2022.
  • Average Non-cash Items over 5 years is $5.9 million, with a median of $2.7 million recorded in 2024.
  • The sharpest move saw Non-cash Items plummeted 99.98% in 2022, then surged 13219.49% in 2023.
  • Over 5 years, Non-cash Items stood at $8.5 million in 2021, then skyrocketed by 204.07% to $25.7 million in 2022, then plummeted by 34.23% to $16.9 million in 2023, then tumbled by 65.49% to $5.8 million in 2024, then dropped by 17.3% to $4.8 million in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $4.8 million, $1.1 million, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.